Botulinum toxin (BTX) is the most potent biological toxin used for the treatment of urologic conditions. During the last 3 years, the use of BTX has been extended to the treatment of symptomatic benign prostatic hyperplasia, however, the actual mechanism through which BTX can reduce prostate volume and infravesical resistance is not well understood. This article reviews the main effects of BTX in prostate tissues. A critical analysis of the outcomes of patients who were studied in clinical series that used this toxin to treat lower urinary tract symptoms related to benign prostatic hyperplasia is also presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ncpuro0735 | DOI Listing |
Publication Analysis
Top Keywords
benign prostatic
12
prostatic hyperplasia
12
botulinum toxin
8
toxin treatment
8
lower urinary
8
urinary tract
8
tract symptoms
8
symptoms benign
8
treatment lower
4
hyperplasia botulinum
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!